Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica

Highlights • Nanoliposome adjuvant induced a robust mucosal and systemic response towards an amebiasis antigen. • Vaccine induced mucosal IgA inhibited adherence of E. histolytica to target cells in vitro. • This adjuvant is compatible with the use of all-trans retinoic acid as a co-adjuvant. • The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2017-02, Vol.35 (6), p.916-922
Hauptverfasser: Abhyankar, Mayuresh M, Noor, Zannatun, Tomai, Mark A, Elvecrog, James, Fox, Christopher B, Petri, William A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Nanoliposome adjuvant induced a robust mucosal and systemic response towards an amebiasis antigen. • Vaccine induced mucosal IgA inhibited adherence of E. histolytica to target cells in vitro. • This adjuvant is compatible with the use of all-trans retinoic acid as a co-adjuvant. • The adjuvant showed potential to elicit protective response against E. histolytica.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2016.12.057